Ozempic, Botox, Eliquis: How Tariffs on Europe Could Impact Drug Prices (And What To Do About It)

Doctor, hands or shelf with medication at pharmacy for inventory.

With approximately 60% of prescription drugs coming from Europe, including major brands like Ozempic, Botox and Eliquis, many Americans are wondering if the 15% tariff established under Trump's EU trade deal will make their medications more expensive. The answer is, unfortunately, not so straightforward.

While pharmaceutical companies enjoy generous profit margins on brand name drugs to potentially absorb Trump's tariffs, margins on generics are much thinner. And it's generics that account for 90% of prescriptions in the U.S., according to the United States Pharmacopeial Convention.